Optimizing Immune Cell Target Selection to Deliver Effective Autoimmune Therapies

Time: 11:00 am
day: Conference Day One Teal Track P1

Details:

• Evaluate which immune cell targets have demonstrated the greatest therapeutic benefits to guide treatment decisions
• Understand patient tolerance to targeting alternative immune cells to optimize safety and efficacy
• Leverage insights from Nkarta Therapeutics’ NK cell-based Non-Hodgkins Lymphoma therapy to predict autoimmune success

Speakers:

Shawn Rose Shawn Rose is Chief Medical Officer and Head of R&D at Nkarta Inc., with over a dozen programs advanced from discovery to clinic, including approvals Read more